TrialDiabetes care2025

Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial.

Schafer C Boeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.